News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,323 Results
Type
Article (67141)
Company Profile (167)
Press Release (610015)
Multimedia
Podcasts (57)
Webinars (12)
Section
Business (183546)
Career Advice (2838)
Deals (32775)
Drug Delivery (105)
Drug Development (80699)
Employer Resources (163)
FDA (16787)
Job Trends (14761)
News (322864)
Policy (32286)
Tag
Academia (2922)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (88)
Alliances (50682)
ALS (95)
Alzheimer's disease (1460)
Antibody-drug conjugate (ADC) (127)
Approvals (16770)
Artificial intelligence (271)
Autoimmune disease (23)
Automation (15)
Bankruptcy (348)
Best Places to Work (11464)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (112)
Bladder cancer (76)
Brain cancer (30)
Breast cancer (286)
Cancer (2326)
Cardiovascular disease (184)
Career advice (2384)
Career pathing (34)
CAR-T (163)
Cell therapy (454)
Cervical cancer (18)
Clinical research (65179)
Collaboration (866)
Company closure (1)
Compensation (292)
Complete response letters (25)
COVID-19 (2721)
CRISPR (45)
C-suite (246)
Cystic fibrosis (105)
Data (2218)
Decentralized trials (2)
Denatured (22)
Depression (50)
Diabetes (265)
Diagnostics (6343)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (128)
Drug pricing (116)
Drug shortages (24)
Duchenne muscular dystrophy (98)
Earnings (66919)
Editorial (41)
Employer branding (20)
Employer resources (143)
Events (90900)
Executive appointments (744)
FDA (18084)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (771)
Gene editing (110)
Generative AI (27)
Gene therapy (329)
GLP-1 (732)
Government (4403)
Grass and pollen (6)
Guidances (66)
Healthcare (18749)
Huntington's disease (19)
IgA nephropathy (29)
Immunology and inflammation (122)
Indications (30)
Infectious disease (2875)
Inflammatory bowel disease (139)
Inflation Reduction Act (7)
Influenza (52)
Intellectual property (101)
Interviews (531)
IPO (14946)
IRA (43)
Job creations (3710)
Job search strategy (1987)
Kidney cancer (11)
Labor market (32)
Layoffs (449)
Leadership (23)
Legal (7060)
Liver cancer (77)
Lung cancer (327)
Lymphoma (153)
Machine learning (7)
Management (57)
Manufacturing (303)
MASH (67)
Medical device (12628)
Medtech (12632)
Mergers & acquisitions (18353)
Metabolic disorders (684)
Multiple sclerosis (86)
NASH (20)
Neurodegenerative disease (104)
Neuropsychiatric disorders (27)
Neuroscience (2029)
NextGen: Class of 2025 (6623)
Non-profit (4869)
Now hiring (27)
Obesity (357)
Opinion (248)
Ovarian cancer (77)
Pain (92)
Pancreatic cancer (82)
Parkinson's disease (155)
Partnered (23)
Patents (241)
Patient recruitment (116)
Peanut (48)
People (54653)
Pharmaceutical (44)
Pharmacy benefit managers (17)
Phase I (20239)
Phase II (28599)
Phase III (21385)
Pipeline (1209)
Policy (145)
Postmarket research (2706)
Preclinical (9091)
Press Release (70)
Prostate cancer (107)
Psychedelics (35)
Radiopharmaceuticals (244)
Rare diseases (404)
Real estate (6045)
Recruiting (68)
Regulatory (23000)
Reports (32)
Research institute (2634)
Resumes & cover letters (453)
Rett syndrome (5)
RNA editing (4)
RSV (48)
Schizophrenia (79)
Series A (128)
Series B (83)
Service/supplier (11)
Sickle cell disease (56)
Special edition (18)
Spinal muscular atrophy (158)
Sponsored (33)
Startups (3519)
State (2)
Stomach cancer (10)
Supply chain (65)
Tariffs (35)
The Weekly (33)
Vaccines (758)
Venture capitalists (39)
Weight loss (238)
Women's health (34)
Worklife (19)
Date
Today (117)
Last 7 days (823)
Last 30 days (2487)
Last 365 days (31379)
2025 (10333)
2024 (33772)
2023 (38302)
2022 (49095)
2021 (53467)
2020 (52477)
2019 (46226)
2018 (35188)
2017 (32252)
2016 (31629)
2015 (36848)
2014 (29493)
2013 (26205)
2012 (27252)
2011 (27872)
2010 (26608)
Location
Africa (938)
Alabama (56)
Alaska (6)
Arizona (195)
Arkansas (13)
Asia (41671)
Australia (7307)
California (5578)
Canada (1921)
China (524)
Colorado (261)
Connecticut (272)
Delaware (132)
Europe (93898)
Florida (855)
Georgia (188)
Idaho (54)
Illinois (537)
India (26)
Indiana (288)
Iowa (9)
Japan (164)
Kansas (97)
Kentucky (23)
Louisiana (12)
Maine (66)
Maryland (845)
Massachusetts (4118)
Michigan (216)
Minnesota (345)
Mississippi (2)
Missouri (86)
Montana (31)
Nebraska (25)
Nevada (62)
New Hampshire (62)
New Jersey (1672)
New Mexico (31)
New York (1712)
North Carolina (954)
North Dakota (9)
Northern California (2397)
Ohio (203)
Oklahoma (15)
Oregon (35)
Pennsylvania (1238)
Puerto Rico (13)
Rhode Island (29)
South America (1247)
South Carolina (24)
South Dakota (1)
Southern California (2134)
Tennessee (97)
Texas (866)
United States (21585)
Utah (172)
Virginia (150)
Washington D.C. (64)
Washington State (523)
West Virginia (2)
Wisconsin (51)
677,323 Results for "whitehead institute mit center for genome research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
The Patient’s Perspective with Tom Whitehead
In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace’s Head of Insights Lori Ellis talks to Tom Whitehead, co-founder of the Emily Whitehead Foundation, about how standard care, cell and gene therapies and their impact on patients.
January 30, 2025
·
1 min read
·
Lori Ellis
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Business
Navigating Patient Journeys with Tom Whitehead
In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace’s Head of Insights Lori Ellis and Tom Whitehead continue to discuss the patient and caregiver experience, where Tom gives his insights to the future of CGTs.
February 13, 2025
·
1 min read
·
Lori Ellis
Business
Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing Technology
Chroma Medicine, Inc. (Chroma) a genomic medicine company pioneering single-course epigenetic editing therapeutics, today announced it has entered into an exclusive license agreement with the Whitehead Institute to access intellectual property and technology developed in the lab of Chroma co-founder Jonathan Weissman, Ph.D.
June 27, 2024
·
2 min read
Press Releases
HUNTSMAN CANCER INSTITUTE BREAKS GROUND ON COMPREHENSIVE CANCER CENTER IN VINEYARD: EXPANDING ACCESS TO WORLD-CLASS CANCER CARE AND LIFESAVING RESEARCH TO MORE UTAH COMMUNITIES
April 11, 2025
·
8 min read
Press Releases
BioSkryb Genomics and Ultima Genomics Launch Collaborative Grant Program to Advance Oncology Research
April 23, 2025
·
5 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.
June 13, 2024
·
5 min read
Press Releases
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
April 30, 2025
·
5 min read
Business
Bayer and Broad Institute of MIT and Harvard Extend Research Collaboration to Develop New Cancer Therapies
Bayer and the Broad Institute of MIT and Harvard today announced that they have extended their research collaboration of 10 years by an additional five years, to develop and advance innovative cancer treatments.
November 2, 2023
·
4 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc. announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, have executed a memorandum of understanding to implement a pilot program where cancer patients would be enrolled on the Veris Cancer Care Platform™.
April 30, 2024
·
7 min read
1 of 67,733
Next
